Detalles de la búsqueda
1.
Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma.
Hematol Oncol
; 41(1): 39-49, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36305717
2.
Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma.
Am J Hematol
; 98(3): 464-471, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36629030
3.
Management of post-transplant lymphoproliferative disorders.
Br J Haematol
; 182(3): 330-343, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29741774
4.
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era.
Blood Adv
; 7(23): 7295-7303, 2023 12 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37729621
5.
Increasing tissue requirements in lymphoma trials may exclude patients with high-risk disease or worse prognosis.
Blood Adv
; 6(24): 6180-6186, 2022 12 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36170803
6.
PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts.
Blood Cancer J
; 12(5): 78, 2022 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35504884
7.
Clearance of Hepatitis C Virus (HCV) Is Associated With Improved Outcomes in HCV-Associated Lymphoma.
Clin Lymphoma Myeloma Leuk
; 21(2): e185-e193, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33132102
8.
Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study.
Blood Cancer J
; 11(9): 160, 2021 09 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34564694
9.
Lymphoma survivors have an increased long-term risk of chronic kidney disease.
Leuk Lymphoma
; 61(12): 2923-2930, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32654590
Resultados
1 -
9
de 9
1
Próxima >
>>